Introduction
============

Ventilator-associated pneumonia (VAP) remains a significant problem within ICUs. There is a growing recognition of the impact of critical-illness-induced immunoparesis on the pathogenesis of VAP, but the mechanisms of this immunoparesis remain incompletely understood. We hypothesised that, because of limitations in their routine detection, *Mycoplasmataceae*are more prevalent amongst patients with VAP than previously recognised, and that these organisms potentially impair immune cell function.

Methods
=======

Two cohorts \[[@B1],[@B2]\], totalling 159 patients, were recruited from 12 UK ICUs; all patients had suspected VAP and underwent bronchoscopy and bronchoalveolar lavage. VAP was defined as growth of organisms at \>10^4^CFU/ml on conventional culture. Thirty-six healthy donors underwent lavage for comparison. Samples were tested for *Mycoplasmataceae*(*Mycoplasma*and *Ureaplasma*spp.) by PCR, and positive samples underwent sequencing for speciation. Additionally, healthy donor monocytes and macrophages (MDM) were exposed to *Mycoplasma salivarium*and their ability to respond to lipopolysaccharide and undertake phagocytosis was assessed.

Results
=======

*Mycoplasmataceae*were found in 48% of patients with VAP, compared with 14% of patients without VAP (*P*\< 0.0001). Patients with sterile lavage had a similar prevalence to healthy donor lavage (10 vs. 8%, *P*= 0.54). The commonest organism identified was *M. salivarium*. Human blood monocytes and MDM incubated with *M. salivarium*displayed impaired cytokine responses to lipopolysaccharide and MDM demonstrated impaired phagocytosis.

Conclusion
==========

This study demonstrates a high prevalence of *Mycoplasmataceae*amongst patients with VAP, with a markedly lower prevalence amongst patients with suspected VAP in whom subsequent cultures refuted the diagnosis. The commonest organism found, *M. salivarium*, is able to profoundly impair the functions of key immune cells and thus suggests that *Mycoplasmataceae*may contribute to VAP pathogenesis.
